Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Photronics Inc.

Start price
Target price
Perf. (%)
€21.80
26.07.22
€40.00
26.07.23
7.75%
27.07.23

buy
US Physical Therapy Inc.

Start price
Target price
Perf. (%)
€122.00
26.07.22
-
26.07.23
-9.84%
26.07.23

buy
Clearfield Inc.

Start price
Target price
Perf. (%)
€74.00
26.07.22
-
26.07.23
-41.49%
26.07.23

buy
A10 Networks

Start price
Target price
Perf. (%)
€14.02
26.07.22
-
26.07.23
-4.96%
26.07.23

buy
Barco N.V.

Start price
Target price
Perf. (%)
€25.26
26.07.22
-
26.07.23
-18.69%
26.07.23

buy
Powercell Sweden AB

Start price
Target price
Perf. (%)
€15.24
25.07.22
-
25.07.26
-80.85%
11.03.24

Could be worthwhile Investment >10% per year
buy
Discovery Silver Corp.

Start price
Target price
Perf. (%)
€0.80
25.07.22
-
25.07.26
-39.87%
11.03.24

Could be worthwhile Investment >10% per year
va-Q-tec AG

Start price
Target price
Perf. (%)
€12.28
25.07.22
-
25.07.23
33.88%
08.12.22

Risky Investment
buy
Hallador Energy Company

Start price
Target price
Perf. (%)
€6.65
25.07.22
-
25.07.23
23.76%
08.12.22

Could be worthwhile Investment >10% per year
buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€54.80
25.07.22
€55.00
25.07.23
-16.02%
22.03.23

EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
buy
Mineral Resources Ltd

Start price
Target price
Perf. (%)
€32.50
25.07.22
€50.00
25.07.23
39.09%
26.07.23

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Fair valuation
buy
Eldorado Gold Corp.

Start price
Target price
Perf. (%)
€5.51
25.07.22
-
25.07.23
13.54%
16.08.22

EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
buy
First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€6.51
25.07.22
-
25.07.23
27.47%
09.08.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Endeavour Silver Corp.

Start price
Target price
Perf. (%)
€3.14
25.07.22
-
25.07.23
17.18%
09.08.22

Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
EBIT growth > 30% per year expected
buy
Hecla Mining Corp.

Start price
Target price
Perf. (%)
€3.78
25.07.22
-
25.07.23
23.80%
09.08.22

Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
StoneMor Inc.

Start price
Target price
Perf. (%)
€3.30
25.07.22
€4.00
25.07.23
7.88%
26.07.23

buy
Tonix Pharmaceuticals Holding Corp.

Start price
Target price
Perf. (%)
€8.56
25.07.22
€12.50
25.07.23
26.95%
26.07.22

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Little innovation
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€9.55
25.07.22
€20.00
31.12.24
-75.71%
08.05.23

Could be very worthwhile Investment >20% year
buy
Canadian Solar Inc.

Start price
Target price
Perf. (%)
€32.01
23.07.22
€40.00
23.07.23
10.40%
28.07.22

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€53.80
23.07.22
€55.00
23.11.23
13.10%
29.07.22

Well known brand
Market Leader or Top 3
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Northern Data AG

Start price
Target price
Perf. (%)
€23.14
21.07.22
-
21.07.23
-13.74%
22.07.23

Probably not worthwhile Investment
EBIT decline/stagnation expected
overvalued
Increased challenges to pay loans and raise capital
Valneva SE

Start price
Target price
Perf. (%)
€9.82
21.07.22
-
21.07.23
-30.16%
22.07.23

Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
Corestate Capital Holding SA

Start price
Target price
Perf. (%)
€1.83
21.07.22
-
21.07.23
-76.99%
22.07.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
buy
Kandi Technologies Corp.

Start price
Target price
Perf. (%)
€2.63
21.07.22
€3.00
21.07.23
-19.90%
11.03.23

EBIT growth >5% per year expected
Innovative
Future proof or reliable business model
Sustainability is little important
buy
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.37
21.07.22
€5.30
21.07.23
-21.42%
11.03.23

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected